Oral Contraceptive Pills Market: Snapshot
The highly competitive oral contraceptive pills market is marked by the presence of several generic product manufacturers, most of which resort to price reduction and free samples to sustain in the market. Oral contraceptive pills are the most common form of reversible contraception in most developed economies of the world, such as Western Europe, the U.S., Canada, and Australia. The adoption and prescription pattern for oral contraceptive pills varies by region, price, and level of awareness and companies have been taking these factors into consideration to up their share in the market.
The opportunity in the global oral contraceptive pills market was reported to be US$13.1 bn in 2014 and is anticipated to be worth US$22.9 bn by 2023, registering a steady CAGR of 6.6% therein.
Generic Oral Contraceptive Pills Enjoy Larger Share in Global Market
By type of product, the oral contraceptive pills market has been segmented into progestin-only, combination, and others. The combination oral contraceptive pills segment led the overall market in 2014 and is projected to register the highest growth rate over the course of the forecast period. This growth can be attributed to their higher efficiency in preventing pregnancies, their easy availability, and their rising preference among consumers.
On the basis of category, the market is bifurcated into generic oral contraceptive pills and branded pills. In 2014, generic oral contraceptive pills led the overall market and this segment is projected to record the fastest growth rate by 2023. The growth of this segment can be attributed to the widespread adoption of generic contraceptives facilitated by their low prices and ease of use.
Favorable Reimbursement Policies in U.S. Spur Adoption of Oral Contraceptive Pills in North America
The global contraceptive pills market is geographically segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. North America led the global contraceptive pills market in 2014 primarily owing to a greater incidence of unintended pregnancies in the region. The Centers for Disease Control and Prevention (CDC) states in a study that between 2006 and 2010, a 37% of the total pregnancies in the U.S were unintended. A significant proportion of these pregnancies led to abortions, which resulted in a massive yet preventable healthcare expenditure. In a bid to curb this avoidable healthcare expense, the governments of North American countries are encouraging women to opt for modern and more effective contraceptive options. The enforcement of the Affordable Care Act, or Obamacare, in the U.S. and various awareness programs by non-profit organizations have led to the availability of favorable reimbursement policies and the increased sale of emergency oral contraceptive pills in the region.
Asia Pacific is viewed as one of the most attractive market for oral contraceptive pills in the course of the forecast period thanks to the steady economic development in countries such as Singapore, India, China, Australia, and Philippines. This economic growth has resulted in the increasing disposable income of the people, surging awareness about family planning and contraceptives, and the desire for healthier living. This, in turn, has led to the rising adoption rate of oral contraceptive pills in the region.
The leading players competing in the global oral contraceptive pills market include Bayer AG, Janssen Global Services, LLC, Allergan,plc (Actavis), Teva Pharmaceutical Industries Ltd., Piramal Enterprises Ltd., Pfizer, Inc., Merck & Co., Inc., and Mankind Pharma Ltd.
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
2.1 Global Oral Contraceptive Pills Market, by Geography, 2014–2023 (US$ Mn)
2.2 Global Oral Contraceptive Pills Market, by Type, 2014 (US$ Mn)
2.3 Oral Contraceptive Pills Market Snapshot
Chapter 3 Oral Contraceptive Pills Market– Industry Analysis
3.2 Market Drivers
3.2.1 High incident rate of unintended pregnancies is leading to unmet contraceptive needs
3.2.2 Awareness programs by government and NGOs are promoting the use of contraceptive pills globally
3.2.3 Increasing maternal age and late pregnancies
3.3.1 Side effects associated with the use of contraceptive drugs
3.4.1 Ethical and social issues restrict the use or subsidies on contraceptives in some countries
3.4.2 Presence of large unmet contraceptive needs in emerging Asian and African countries
3.5 Porter’s Five Forces Analysis
3.6 Market Attractiveness Analysis– Oral Contraceptive Pills Market, by Geography (2014) (%)
3.7 Heat Map Analysis, by Key Players, 2014
3.8 Adoption and Prescription Pattern Analysis
3.9 Market Scenario of Oral Contraceptive Pills
Chapter 4 Market Segmentation – By Type
4.2 Global Oral Contraceptive Pills Market Revenue, by Type, 2013–2023 (US$ Mn)
4.3 Global Combination Pills Market Revenue, 2013–2023 (US$ Mn)
4.3.1 Global Monophasic Pills Market Revenue, 2013–2023 (US$ Mn)
4.3.2 Global Triphasic Pills Market Revenue, 2013–2023 (US$ Mn)
4.3.3 Global Other Combination Pills Market Revenue, 2013–2023 (US$ Mn)
4.4 Global Progestin Only Pills Market Revenue, 2013–2023 (US$ Mn)
4.5 Global Other Pills Market Revenue, 2013–2023 (US$ Mn)
Chapter 5 Market Segmentation – By Category
5.2 Global Oral Contraceptive Pills Market Revenue, by Category, 2013–2023 (US$ Mn)
5.3 Global Generic Oral Contraceptive Pills Market Revenue, 2013–2023 (US$ Mn)
5.4 Global Branded Oral Contraceptive Pills Market Revenue, 2013–2023 (US$ Mn)
Chapter 6 Market Segmentation – By Geography
6.2 Global Oral Contraceptive Pills Market Revenue, by Geography, 2013–2023 (US$ Mn)
6.3 North America Oral Contraceptive Pills Market Revenue, by Country, 2013–2023 (US$ Mn)
6.4 Europe Oral Contraceptive Pills Market Revenue, by Country, 2013–2023 (US$ Mn)
6.5 Asia Pacific Oral Contraceptive Pills Market Revenue, by Country, 2013–2023 (US$ Mn)
6.6 LATAM Oral Contraceptive Pills Market Revenue, by Country, 2013–2023 (US$ Mn)
6.7 MEA Oral Contraceptive Pills Market Revenue, by Country, 2013–2023 (US$ Mn)
Chapter 7 Company Profiles
7.1 Allergan, plc (Actavis)
7.2 Bayer AG
7.3 Janssen Global Services, LLC
7.4 Mankind Pharma Ltd.
7.5 Merck & Co., Inc.
7.6 Pfizer, Inc.
7.7 Piramal Enterprises Ltd.
7.8 Teva Pharmaceutical Industries Ltd
Oral contraceptive pills are birth control pills including progestin and estrogen hormones. These hormones induce contraception/birth control by preventing ovulation. These pills are also known as combined pills or combined oral contraceptive pills (COCP). Combined oral contraceptive pills are available in five different packs: the 21-day pack, the 24-day pack, the 28-day pack, the 91-day pack and the four-phase regimen. Bayer’s Yaz and Loestrin are the most widely preferred brands of the 24-day pack. Barr Laboratories’ Seasonale and Teva Pharmaceutical Industries’ Seasonique are preferred in the 91-day pack sub-segment. In the four-phase regimen, Bayer’s Natazia dominates the market.
Oral contraceptive pills are the most common form of reversible contraception in the developed economies of the world such as the U.S., Canada, the Western Europe and Australia. Their high effectiveness (99.9% when accurately used and 92% when typically used) and convenience in use (in comparison to contraceptive devices, especially implants), drive the oral contraceptive pills segment.
This report provides in-depth analysis of the global oral contraceptives pills market. The stakeholders for this report include companies involved in the research and development, manufacturing and commercialization of oral contraceptive pills, suppliers and new entrants planning to invest in this market. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition for different oral contraceptive pills in the five major regions.
The market overview section of this report analyzes market dynamics such as drivers, restraints and opportunities that influence the oral contraceptive pills market in the current and future scenario. Further, Porter’s five forces analysis and market attractiveness analysis have been included in market overview section in order to explain the intensity of competition in the market. Porter’s five forces analysis is also elucidated in the section to understand the attractiveness of the oral contraceptive pills market in terms of the five different attributes that have an effect on the sustenance of the players in the oral contraceptive pills market. Competitive scenario among the market players is analyzed through a heat map of major market players in the competitive landscape section of the report. All these factors will help the market players to decide about the business strategies and plans to be incurred in future for strengthening their position in the global market.
Based on the product types, the global oral contraceptives market is segmented into combination pills, progestin only pills and others. Combination pills are further categorized into three segments including monophasic pills, triphasic pills and others. Market revenue in terms of US$ Mn for the period 2013 to 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 is analyzed for the various types of oral contraceptive pills.
Geographically, the oral contraceptive pills market has been differentiated into five major regions: North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW). This section of the report provides with the market estimation in terms of revenue (US$ Mn) of contraceptive pills market in these five regions from 2013 to 2023. Market revenue for oral contraceptive pills is also provided for geographies along with CAGR % for period 2015 to 2023, considering 2014 as the base year.
This report also includes recommendations section that will assist new companies in establishing their presence and market players in expanding their market share in the oral contraceptive pills market. The report concludes with the company profile section which includes company overview, financial overview, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include Actavis, Inc., Bayers AG, Merck & Co., Inc., and Teva Pharmaceutical Industries Ltd.
The global oral contraceptive pills market is segmented into the following categories:
Global Oral Contraceptive Pills Market, by Types
- Progestin Only
Global Oral Contraceptive Pills Market, by Category
Global Oral Contraceptive Pills Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Rest pf APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- Rest of MEA